E. del Barco

2.5k total citations
66 papers, 629 citations indexed

About

E. del Barco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, E. del Barco has authored 66 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 20 papers in Otorhinolaryngology. Recurrent topics in E. del Barco's work include Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). E. del Barco is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). E. del Barco collaborates with scholars based in Spain, United States and United Kingdom. E. del Barco's co-authors include Juan Jesús Cruz, Ricard Mesı́a, Alberto Ocaña, Juan J. Grau, Atanasio Pandiella, Bartomeu Massutí, Javier Martínez‐Trufero, Reyes Bernabé, Manuel Dómine and Delvys Rodríguez‐Abreu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

E. del Barco

57 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. del Barco Spain 17 341 260 149 145 118 66 629
Sang Hoon Chun South Korea 16 237 0.7× 178 0.7× 56 0.4× 193 1.3× 141 1.2× 54 564
Xiao-Jing Du China 8 497 1.5× 194 0.7× 164 1.1× 67 0.5× 60 0.5× 9 677
Jeltje Schulten Germany 10 334 1.0× 222 0.9× 313 2.1× 117 0.8× 49 0.4× 14 603
Carlo Furlan Italy 13 180 0.5× 252 1.0× 88 0.6× 69 0.5× 113 1.0× 29 515
Wang‐Zhong Li China 13 275 0.8× 116 0.4× 205 1.4× 61 0.4× 71 0.6× 41 523
Qin Zhou China 13 128 0.4× 124 0.5× 112 0.8× 101 0.7× 80 0.7× 39 457
Virginia Arrazubi Spain 12 372 1.1× 235 0.9× 34 0.2× 136 0.9× 109 0.9× 48 641
Chen Zhou Canada 14 307 0.9× 157 0.6× 38 0.3× 117 0.8× 95 0.8× 40 610
Milena Perez Mak Brazil 12 399 1.2× 234 0.9× 46 0.3× 189 1.3× 137 1.2× 34 664
P Vodvářka Czechia 9 368 1.1× 232 0.9× 178 1.2× 118 0.8× 94 0.8× 16 534

Countries citing papers authored by E. del Barco

Since Specialization
Citations

This map shows the geographic impact of E. del Barco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. del Barco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. del Barco more than expected).

Fields of papers citing papers by E. del Barco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. del Barco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. del Barco. The network helps show where E. del Barco may publish in the future.

Co-authorship network of co-authors of E. del Barco

This figure shows the co-authorship network connecting the top 25 collaborators of E. del Barco. A scholar is included among the top collaborators of E. del Barco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. del Barco. E. del Barco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corral-Gudino, Luís, et al.. (2025). Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review. Clinical and Translational Radiation Oncology. 52. 100930–100930. 1 indexed citations
2.
Casanova, Alfredo G., E. del Barco, A. Olivares, et al.. (2025). Evaluating Urinary Biomarkers for Early Detection of Kidney Damage in Immune Checkpoint Inhibitors-Treated Patients. American Journal of Nephrology. 1–12.
3.
Montero, Juan Carlos, et al.. (2024). Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer. International Journal of Molecular Sciences. 25(4). 2048–2048. 4 indexed citations
4.
Barco, E. del, Esperanza Garcı́a, Berta Serrano, et al.. (2024). Role of routine uterine artery Doppler at 18–22 and 24–28 weeks' gestation following routine first‐trimester screening for pre‐eclampsia. Ultrasound in Obstetrics and Gynecology. 65(1). 63–70. 1 indexed citations
5.
6.
Calvo, Virginia, Enric Carcereny, Delvys Rodríguez‐Abreu, et al.. (2024). Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk. Lung Cancer. 195. 107920–107920. 3 indexed citations
7.
Torrente, María, Luca Costabello, Virginia Calvo, et al.. (2023). Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer. JCO Clinical Cancer Informatics. 7(7). e2200062–e2200062. 11 indexed citations
8.
Miramontes‐González, José Pablo, Ana Martín‐Garcia, Rocío Eirós, et al.. (2023). Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data. Cancers. 15(17). 4293–4293. 5 indexed citations
9.
Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations
10.
Rubió‐Casadevall, Jordi, Beatriz Cirauqui, Javier Martínez‐Trufero, et al.. (2023). TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck. Frontiers in Oncology. 13. 1226939–1226939. 7 indexed citations
11.
Barco, E. del, José Pablo Miramontes‐González, Luis M. Pérez‐Belmonte, et al.. (2022). Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy. Frontiers in Bioscience-Landmark. 27(3). 88–88. 6 indexed citations
12.
Calvo, Virginia, Manuel Cobo, Delvys Rodríguez‐Abreu, et al.. (2022). 39P Determination of essential biomarkers in lung cancer: A real-world data study in Spain. Annals of Oncology. 33. S50–S50. 1 indexed citations
13.
14.
Casanova, Alfredo G., Laura Vicente-Vicente, María Teresa Hernández-Sánchez, et al.. (2019). Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations. Biomedicine & Pharmacotherapy. 121. 109684–109684. 27 indexed citations
15.
Provencio, Mariano, Enric Carcereny, Delvys Rodríguez‐Abreu, et al.. (2019). Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study). Translational Lung Cancer Research. 8(4). 461–475. 43 indexed citations
16.
Fernández-Mateos, Javier, Miguel Pastor Borgoñón, Elísabeth Pérez-Ruiz, et al.. (2019). Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population. Cancers. 11(4). 493–493. 17 indexed citations
17.
Rodrí­guez, Pilar Rodriguez, Mercedes Sánchez‐Barba, & E. del Barco. (2017). Investigación en musicoterapia sobre la relajación, estado emocional y reducción del dolor en el enfermo oncológico. 1(1). 32–47. 1 indexed citations
18.
Pastor, María A., E. del Barco, Pedro Pérez Segura, et al.. (2017). SEOM clinical guideline in nasopharynx cancer (2017). Clinical & Translational Oncology. 20(1). 84–88. 25 indexed citations
19.
Barco, E. del, et al.. (2016). Carcinoma nasofaríngeo familiar en zona no endémica. Presentación de 3 familias. Acta Otorrinolaringológica Española. 68(3). 164–168. 3 indexed citations
20.
Tejada, J., Xixiang Zhang, & E. del Barco. (1999). Quantum tunneling of the magnetic moment. 1(1). 25–38. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Hoon Chun Breakdown of academic impact, for papers by Xiao-Jing Du Breakdown of academic impact, for papers by Jeltje Schulten Breakdown of academic impact, for papers by Carlo Furlan Breakdown of academic impact, for papers by Wang‐Zhong Li Breakdown of academic impact, for papers by Qin Zhou Breakdown of academic impact, for papers by Virginia Arrazubi Breakdown of academic impact, for papers by Chen Zhou Breakdown of academic impact, for papers by Milena Perez Mak Breakdown of academic impact, for papers by P Vodvářka
Rankless by CCL
2026